(Q40472170)

20 September 2017

title

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production. (English)

1 reference

20 September 2017

0 references

1 reference

Barban V

1

1 reference

20 September 2017

Girerd Y

2

1 reference

20 September 2017

Aguirre M

3

1 reference

20 September 2017

Gulia S

4

1 reference

20 September 2017

Pétiard F

5

1 reference

20 September 2017

Riou P

6

1 reference

20 September 2017

Barrere B

7

1 reference

20 September 2017

Lang J

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

15

1 reference

20 September 2017

page(s)

2941-2950

1 reference

THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Pathogenesis and pathophysiology of yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Effects of yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Effects of yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Effects of yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Prevention of yellow fever in persons traveling to the tropics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Live flavivirus vaccines: reasons for caution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Yellow fever vaccine safety: a reality or a myth?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

THE TRANSMISSION OF YELLOW FEVER TO MACACUS RHESUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Neuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus Spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Comparison of neurovirulence of different strains of yellow fever virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

A W.H.O. collaborative study of in vitro and in vivo methods for the assay of yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

The epidemiology of yellow fever in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.082

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.06.082

1 reference

20 September 2017

1 reference